Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases November 4, 2021August 16, 2022
Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023 June 21, 2023June 21, 2023
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting April 17, 2024April 17, 2024